Publication date: Oct 14, 2025
Individual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiation of treatment.
| Concepts | Keywords |
|---|---|
| Genexpert | Drug-sensitive TB |
| Microbiologically | post-tuberculosis respiratory morbidity |
| Outpatient | Pulmonary Rehabilitation |
| Smartphone | pulmonary tuberculosis |
| Week |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | MESH | Morbidity |
| disease | MESH | dyspnea |
| disease | MESH | TB meningitis |
| disease | MESH | cardiovascular disease |
| disease | MESH | coronary artery disease |
| disease | MESH | cardiac failure |
| disease | MESH | Infection |
| disease | MESH | pulmonary tuberculosis |